Unité de recherche en santé des populations (URESP), Hôpital du Saint-Sacrement, 1050 chemin Sainte-Foy, Québec, QC, Canada, G1S 4L8.
J Natl Cancer Inst. 2013 Feb 20;105(4):280-92. doi: 10.1093/jnci/djs512. Epub 2013 Jan 24.
We lack comprehensive information about the extent of out-of-pocket costs after diagnosis of early breast cancer and their effects on the family's financial situation.
This longitudinal study assessed out-of-pocket costs and wage losses during the first year after diagnosis of early breast cancer among Canadian women and spouses. Out-of-pocket costs for treatments and follow-up, consultations with other practitioners, home help, clothing, and natural health products were estimated, with information collected from telephone interviews. Generalized linear models were used to identify women at risk of having higher costs and the effects of out-of-pocket costs on perceptions of the family's financial situation.
Overall, 829 women (participation, 86.2%) and 391 spouses participated. Women's median net out-of-pocket costs during the year after diagnosis were $1002 (2003 Canadian dollars; mean = $1365; SD = $1238), and 74.4% of these costs resulted from treatments and follow-up. Spouses' median costs were $111 (mean = $234; SD = $320), or 9% of couples' total expenses. In multivariable analyses, the percentage of women with out-of-pocket costs of $1773 or more (upper quartile) was statistically significantly associated with higher education, working at diagnosis, living more than 50 km from the hospital where surgery was performed, and having two and three different types of adjuvant treatment (all 2-sided P values ≤ .01). However, when considered simultaneously with wage losses, out-of-pocket costs were not associated with perceived deterioration in the family's financial situation; rather, wage losses were the driving factor.
Overall, out-of-pocket costs from breast cancer for the year after diagnosis are probably not unmanageable for most women. However, some women were at higher risk of experiencing financial burden resulting from these costs.
我们缺乏关于早期乳腺癌诊断后自付费用的全面信息,以及这些费用对家庭财务状况的影响。
本纵向研究评估了加拿大女性及其配偶在早期乳腺癌诊断后第一年的自付费用和工资损失。通过电话访谈收集信息,估算了治疗和随访、咨询其他从业者、家庭帮助、服装和天然保健品的自付费用。使用广义线性模型确定了有较高费用风险的女性,以及自付费用对家庭财务状况感知的影响。
共有 829 名女性(参与率 86.2%)和 391 名配偶参与了研究。女性在诊断后一年内的净自付费用中位数为 1002 加元(2003 年加元;平均值为 1365 加元;标准差为 1238 加元),其中 74.4%的费用来自治疗和随访。配偶的费用中位数为 111 加元(平均值为 234 加元;标准差为 320 加元),占夫妇总费用的 9%。在多变量分析中,自付费用为 1773 加元或更多(上四分位数)的女性比例与较高的教育程度、诊断时工作、居住地距离手术医院 50 公里以上、接受两种或三种不同类型的辅助治疗(所有双侧 P 值均≤.01)显著相关。然而,当与工资损失同时考虑时,自付费用与家庭财务状况恶化的感知无关,而工资损失是主要因素。
总体而言,大多数女性在诊断后一年的乳腺癌自付费用可能是可以承受的。然而,一些女性面临着因这些费用而产生经济负担的更高风险。